Duet BioTherapeutics, a subsidiary of Scopus BioPharma, announces important…
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”)a biopharmaceutical company developing transformative therapeutics for serious diseases with significant unmet medical